Cleared Traditional

K020333 - ATRION MEDICAL QL FLUID DISPENSING SYRINGE

K020333 is an FDA 510(k) clearance for ATRION MEDICAL QL FLUID DISPENSING SYRINGE, manufactured by Atrion Medical Products, Inc.. The device is a Class 2 Cardiovascular device with product code DXT cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K020333 · Atrion Medical Products, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2002
Decision
84d
Days
Class 2
Risk

K020333 is an FDA 510(k) clearance for the ATRION MEDICAL QL FLUID DISPENSING SYRINGE. Classified as Injector And Syringe, Angiographic (product code DXT), Class II - Special Controls.

Submitted by Atrion Medical Products, Inc. (Arab, US). The FDA issued a Cleared decision on April 25, 2002 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1650 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Atrion Medical Products, Inc. devices

FDA 510(k) Submission Details - K020333

510(k) Number K020333 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2002
Decision Date April 25, 2002
Days to Decision 84 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 125d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXT Device Classification - Class 2, Special Controls

Product Code DXT Injector And Syringe, Angiographic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1650
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXT Injector And Syringe, Angiographic

All 119
Devices cleared under the same product code (DXT) and FDA review panel - the closest regulatory comparables to K020333.
MEDRAD SPECTRIS SOLARIS MR INJECTOR SYSTEM
K033247 · Medrad, Inc. · Nov 2003
MEDRAD MANUAL SYRINGE LOADER
K031483 · Medrad, Inc. · Aug 2003
MEDRAD STELLANT CT INJECTOR SYSTEM
K023183 · Medrad, Inc. · Jan 2003
MEDRAD QWIK-FIT SYRINGE
K013815 · Medrad, Inc. · Dec 2001
MODIFICATION TO: MEDRAD SPECTRIS SOLARIS MR INJECTOR SYSTEM
K012950 · Medrad, Inc. · Oct 2001
MONARCH INFLATION SYRINGE
K011811 · Merit Medical Systems, Inc. · Aug 2001